Vaccines Authorized by the Government of Mexico for emergency use:
Vaccine/pharmaceutical company
Number of doses
Trial Phase
Status in Mexico
Authorization date
Doses acquired by the Government of Mexico
BNT162b2 Pfizer/BioNTech
2
III
Emergency use authorization
11/12/20
34.4 million doses
AZD1222 AstraZeneca/Universidad de Oxford
2
III
Emergency use authorization
04/01/21
77.4 million doses
Sputnik V Gamaleya Institute
2
III
Emergency use authorization
02/02/21
24 million doses
Ad5-nCoV CanSino Biologics
1
III
Emergency use authorization
09/02/21
35 million doses
CoronaVac Sinovac
2
III
Emergency use authorization
09/02/21
20 million doses
Upcoming vaccine arrivals in Mexico according to information from the Ministry of Health and the Ministry of Foreign Affairs:
- Pfizer/BioNTech: 658,125 doses arrived in Mexico on March 23;
- Sinovac: 1 million doses arrived on March 18 and 1 million doses are due to arrive on March 27; in addition, all doses of Sinovac vaccine will be delivered between March and July of this year;
- On March 22, 500 thousand doses of Sputnik V vaccine arrived;
- 65 thousand doses of CanSino vaccine will arrive at the end of March.
Vaccines received from December 23, 2020 to March 23, 2021:
Vaccine/pharmaceutical company
Number of doses received
BNT162b2 Pfizer/BioNTech
4,377,750
AZD1222 AstraZeneca/Universidad de Oxford
870,000
Sputnik V Gamaleya Institute
400,000
Ad5-nCoV CanSino Biologics
940,470
CoronaVac Sinovac
3,000,000
Total 9,588,220
Regarding the National Guiding Policy for Vaccination against SARS-CoV-2, as of March 23, 2021, 5,926,967 doses of vaccines against COVID-19 have been applied according to the General Director of Epidemiology of the Ministry of Health, José Luis Alomía Zegarra, as he said at the afternoon conference on March 23.
Vaccines with pending authorization and with clinical studies authorized in Mexico are the following:
